UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 174 filers reported holding UNIQURE NV in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,316,099 | -95.3% | 196,140 | -92.0% | 0.00% | -100.0% |
Q2 2023 | $28,208,997 | -74.0% | 2,461,518 | -54.3% | 0.00% | -60.0% |
Q1 2023 | $108,581,628 | +77.3% | 5,391,342 | +99.6% | 0.01% | -16.7% |
Q4 2022 | $61,230,015 | +19.8% | 2,700,927 | -0.9% | 0.01% | +20.0% |
Q3 2022 | $51,117,000 | -1.6% | 2,724,757 | -2.2% | 0.01% | 0.0% |
Q2 2022 | $51,945,000 | -24.2% | 2,786,683 | -26.5% | 0.01% | 0.0% |
Q1 2022 | $68,549,000 | -23.8% | 3,793,464 | -12.6% | 0.01% | -28.6% |
Q4 2021 | $90,013,000 | -35.9% | 4,340,063 | -1.1% | 0.01% | -36.4% |
Q3 2021 | $140,437,000 | +3.3% | 4,387,263 | -0.6% | 0.01% | 0.0% |
Q2 2021 | $135,934,000 | -10.3% | 4,413,444 | -1.9% | 0.01% | -15.4% |
Q1 2021 | $151,583,000 | -5.7% | 4,499,344 | +1.1% | 0.01% | -7.1% |
Q4 2020 | $160,764,000 | +7.5% | 4,449,609 | +9.6% | 0.01% | -6.7% |
Q3 2020 | $149,522,000 | -14.6% | 4,059,794 | +4.5% | 0.02% | -21.1% |
Q2 2020 | $175,137,000 | -14.9% | 3,886,752 | -10.4% | 0.02% | -32.1% |
Q1 2020 | $205,771,000 | -34.2% | 4,336,587 | -0.6% | 0.03% | -17.6% |
Q4 2019 | $312,580,000 | +102.8% | 4,361,992 | +11.4% | 0.03% | +88.9% |
Q3 2019 | $154,154,000 | -46.9% | 3,916,503 | +5.5% | 0.02% | -47.1% |
Q2 2019 | $290,213,000 | +31.9% | 3,713,535 | +0.7% | 0.03% | +30.8% |
Q1 2019 | $220,036,000 | +108.6% | 3,688,791 | +0.8% | 0.03% | +85.7% |
Q4 2018 | $105,457,000 | -21.4% | 3,659,162 | -0.7% | 0.01% | -6.7% |
Q3 2018 | $134,097,000 | -4.0% | 3,684,992 | -0.3% | 0.02% | -6.2% |
Q2 2018 | $139,659,000 | +87.6% | 3,694,681 | +16.6% | 0.02% | +77.8% |
Q1 2018 | $74,458,000 | +23.4% | 3,168,398 | +2.9% | 0.01% | +28.6% |
Q4 2017 | $60,337,000 | +282.2% | 3,080,008 | +87.3% | 0.01% | +250.0% |
Q3 2017 | $15,786,000 | +63.5% | 1,644,318 | +5.4% | 0.00% | +100.0% |
Q2 2017 | $9,656,000 | +11.5% | 1,560,113 | +4.1% | 0.00% | 0.0% |
Q1 2017 | $8,661,000 | +31.6% | 1,498,463 | +27.5% | 0.00% | 0.0% |
Q4 2016 | $6,580,000 | -23.8% | 1,175,118 | +4.1% | 0.00% | 0.0% |
Q3 2016 | $8,637,000 | +16.6% | 1,128,918 | +12.3% | 0.00% | 0.0% |
Q2 2016 | $7,409,000 | -64.0% | 1,005,219 | -41.9% | 0.00% | -66.7% |
Q1 2016 | $20,558,000 | -45.1% | 1,730,473 | -23.6% | 0.00% | -40.0% |
Q4 2015 | $37,449,000 | -19.4% | 2,264,124 | -0.3% | 0.01% | -28.6% |
Q3 2015 | $46,462,000 | -19.7% | 2,271,979 | +6.0% | 0.01% | 0.0% |
Q2 2015 | $57,861,000 | +35.2% | 2,143,006 | +21.8% | 0.01% | +40.0% |
Q1 2015 | $42,790,000 | +64.2% | 1,759,451 | -0.0% | 0.01% | +66.7% |
Q4 2014 | $26,058,000 | +60.8% | 1,759,490 | +0.0% | 0.00% | +50.0% |
Q3 2014 | $16,204,000 | -32.0% | 1,759,431 | +0.3% | 0.00% | -33.3% |
Q2 2014 | $23,831,000 | -10.4% | 1,753,573 | +2.5% | 0.00% | -25.0% |
Q1 2014 | $26,598,000 | – | 1,710,497 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |